Disrupted-in-schizophrenia-1 (DISC1) Regulates Endoplasmic Reticulum Calcium Dynamics

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Park, Sung Jin ^a   Jeong, Jaehoon ^a   Park, Young Un ^a   Park, Kyung Sun ^a   Lee, Haeryun ^a   Lee, Namgyu ^a   Kim, Sung Mo ^a   Kuroda, Keisuke ^b   Nguyen, Minh Dang ^c   Kaibuchi, Kozo ^b   Park, Sang Ki ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DISC1 PROTEIN, MOUSE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; NERVE PROTEIN; NEUROLEPTIC AGENT; PROTEIN BINDING; VESICULAR TRANSPORT PROTEIN;

ANIMAL; CALCIUM SIGNALING; CELL LINE; DRUG EFFECTS; ENDOPLASMIC RETICULUM; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; MOUSE; PROTEIN TRANSPORT; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; CALCIUM; CALCIUM SIGNALING; CELL LINE; ENDOPLASMIC RETICULUM; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; PROTEIN BINDING; PROTEIN TRANSPORT; PYRAMIDAL CELLS; SCHIZOPHRENIA; VESICULAR TRANSPORT PROTEINS;

EID: 84924020927     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08694     Document Type: Article

References (61)

1. American Psychiatric Association. Diagnostic criteria from DSM-IV-TR. (American Psychiatric Association, 2000).
2. McGrath, J., Saha, S., Chant, D. & Welham, J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 30, 67-76 (2008).
3. Carlsson, A. Does dopamine play a role in schizophrenia? Psychol Med 7, 583-597 (1977).
4. Carlsson, A. Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry 135, 165-173 (1978).
5. Javitt, D. C. & Zukin, S. R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148, 1301-1308 (1991).
6. Tollefson, G. D. et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry 154, 457-465 (1997).
7. Jacobs, P., Brunton, M., Frackiewicz, A. & Newton, M. Studies on a family with three cytogenetic markers. Ann Hum Genet 33, 325-336 (1970).
8. Chubb, J. E., Bradshaw, N. J., Soares, D. C., Porteous, D. J. & Millar, J. K. The DISC locus in psychiatric illness. Mol Psychiatry 13, 36-64 (2008).
9. Kamiya, A. et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 7, 1167-1178 (2005).
10. Park, Y. U. et al. Disrupted-in-schizophrenia 1 (DISC1) plays essential roles in mitochondria in collaboration with Mitofilin. Proc Natl Acad Sci U S A 107, 17785-17790 (2010).
11. Atkin, T. A., MacAskill, A. F., Brandon, N. J. & Kittler, J. T. Disrupted in Schizophrenia-1 regulates intracellular trafficking of mitochondria in neurons. Mol Psychiatry 16, 122-124 (2011).
12. Hayashi-Takagi, A. et al. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat Neurosci 13, 327-332 (2010).
13. Wang, Q. et al. The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function. Mol Psychiatry 16, 1006-1023 (2011).
14. Berridge, M. J. The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium 32, 235-249 (2002).
15. Berridge, M. J. Neuronal calcium signaling. Neuron 21, 13-26 (1998).
16. Fujii, S., Matsumoto, M., Igarashi, K., Kato, H. & Mikoshiba, K. Synaptic plasticity in hippocampal CA1 neurons of mice lacking type 1 inositol-1, 4, 5-trisphosphate receptors. Learn Mem 7, 312-320 (2000).
17. Mattson, M. P. et al. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci 23, 222-229 (2000).
18. Wang, S. & Hsu, S. C. The molecular mechanisms of the mammalian exocyst complex in exocytosis. Biochem Soc Trans 34, 687-690 (2006).
19. Sans, N. et al. NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex. Nat Cell Biol 5, 520-530 (2003).
20. Wiederkehr, A., Du, Y., Pypaert, M., Ferro-Novick, S. & Novick, P. Sec3p is needed for the spatial regulation of secretion and for the inheritance of the cortical endoplasmic reticulum. Mol Biol Cell 14, 4770-478 (2003).
21. Toikkanen, J. H., Miller, K. J., Soderlund, H., Jantti, J. & Keranen, S. The beta subunit of the Sec61p endoplasmic reticulum translocon interacts with the exocyst complex in Saccharomyces cerevisiae. J Biol Chem 278, 20946-20953 (2003).
22. Lipschutz, J. H., Lingappa, V. R. & Mostov, K. E. The exocyst affects protein synthesis by acting on the translocation machinery of the endoplasmic reticulum. J Biol Chem 278, 20954-20960 (2003).
23. Shin, D.M., Zhao, X. S., Zeng, W., Mozhayeva, M. & Muallem, S. The mammalian Sec6/8 complex interacts with Ca(21) signaling complexes and regulates their activity. J Cell Biol 150, 1101-1112 (2000).
24. Andersen, N. J. & Yeaman, C. Sec3-containing exocyst complex is required for desmosome assembly in mammalian epithelial cells. Mol Biol Cell 21, 152-164 (2010).
25. Kuroda, K. et al. Behavioral alterations associated with targeted disruption of exons 2 and 3 of the Disc1 gene in the mouse. Hum Mol Genet 20, 4666-4683 (2011).
26. Dudek, H., Ghosh, A. & Greenberg, M. E. Calcium phosphate transfection ofDNA into neurons in primary culture. Curr Protoc Neurosci Chapter 3, Unit 3 11 (2001).
27. Bozidis, P., Williamson, C. D. & Colberg-Poley, A. M. Isolation of endoplasmic reticulum, mitochondria, andmitochondria-associated membrane fractions from transfected cells and from human cytomegalovirus-infected primary fibroblasts. Curr Protoc Cell Biol Chapter 3, Unit 3 27 (2007).
28. Feldheim, D., Rothblatt, J. & Schekman, R. Topology and functional domains of Sec63p, an endoplasmic reticulum membrane protein required for secretory protein translocation. Mol Cell Biol 12, 3288-3296 (1992).
29. Segal, M. Imaging of calcium variations in living dendritic spines of cultured rat hippocampal neurons. J Physiol 486 (Pt2), 283-295 (1995).
30. Bandyopadhyay, A., Shin, D. W. & Kim, D. H. Regulation of ATP-induced calcium release in COS-7 cells by calcineurin. Biochem J 348 Pt 1, 173-181 (2000).
31. Alvarez, J. & Montero, M. Measuring [Ca21] in the endoplasmic reticulum with aequorin. Cell Calcium 32, 251-260 (2002).
32. Vance, J. E. Phospholipid synthesis in a membrane fraction associated with mitochondria. J Biol Chem 265, 7248-7256 (1990).
33. Min, M. K. et al.Overexpression of Arabidopsis AGD7 causes relocation of Golgilocalized proteins to the endoplasmic reticulum and inhibits protein trafficking in plant cells. Plant Physiol 143, 1601-1614 (2007).
34. Camargo, L. M. et al. Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol Psychiatry 12, 74-86 (2007).
35. Patel, S., Joseph, S. K. & Thomas, A. P. Molecular properties of inositol 1, 4, 5-trisphosphate receptors. Cell Calcium 25, 247-264 (1999).
36. Bradshaw, N. J. et al. PKA phosphorylation of NDE1 is DISC1/PDE4 dependent and modulates its interaction with LIS1 and NDEL1. J Neurosci 31, 9043-9054 (2011).
37. Vanderheyden, V. et al. Regulation of inositol 1, 4, 5-trisphosphate-induced Ca21 release by reversible phosphorylation and dephosphorylation. Biochim Biophys Acta 1793, 959-970 (2009).
38. Pieper, A. A. et al. Differential neuronal localizations and dynamics of phosphorylated and unphosphorylated type 1 inositol 1, 4, 5-trisphosphate receptors. Neuroscience 102, 433-444 (2001).
39. Gordon, J. L. Extracellular ATP: effects, sources and fate. Biochem J 233, 309-319 (1986).
40. Szabadkai, G. & Duchen, M. R. Mitochondria: the hub of cellular Ca21signaling. Physiology (Bethesda) 23, 84-94 (2008).
41. Pozzan, T., Rizzuto, R., Volpe, P. & Meldolesi, J. Molecular and cellular physiology of intracellular calcium stores. Physiol Rev 74, 595-636 (1994).
42. Neve, K. A., Seamans, J. K. & Trantham-Davidson, H. Dopamine receptor signaling. J Recept Signal Transduct Res 24, 165-205 (2004).
43. Rashid, A. J. et al. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci U S A 104, 654-659 (2007).
44. Hasbi, A., O'Dowd, B. F. & George, S. R. Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms. Curr Opin Pharmacol 10, 93-99 (2010).
45. Sczekan, S. R. & Strumwasser, F. Antipsychotic drugs block IP3-dependent Ca(21)-release from rat brain microsomes. Biol Psychiatry 40, 497-502 (1996).
46. Rosse, C. et al. An aPKC-exocyst complex controls paxillin phosphorylation and migration through localised JNK1 activation. PLoS Biol 7, e1000235 (2009).
47. Dellago, H. et al. Exo70, a subunit of the exocyst complex, interacts with SNEV(hPrp19/hPso4) and is involved in pre-mRNA splicing. Biochem J 438, 81-91 (2011).
48. Cameron, A.M. et al. Calcineurin associated with the inositol 1, 4, 5-trisphosphate receptor-FKBP12 complex modulates Ca21 flux. Cell 83, 463-472 (1995).
49. Quinton, T. M., Brown, K. D. & Dean, W. L. Inositol 1, 4, 5-trisphosphatemediated Ca21 release from platelet internal membranes is regulated by differential phosphorylation. Biochemistry 35, 6865-6871 (1996).
50. Cavallini, L., Coassin, M., Borean, A. & Alexandre, A. Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1, 4, 5-trisphosphate receptor and promote its phosphorylation. J Biol Chem 271, 5545-5551 (1996).
51. Lee, D. H. et al. Antiplatelet effects of caffeic acid due to Ca(2) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation. J Atheroscler Thromb 21, 23-37 (2014).
52. Jimerson, D. C. et al. CSF calcium: clinical correlates in affective illness and schizophrenia. Biol Psychiatry 14, 37-51 (1979).
53. Lidow, M. S. Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res Brain Res Rev 43, 70-84 (2003).
54. Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A. & Levitt, P. Diseasespecific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6, 293-301 (2001).
55. Ripova, D., Strunecka, A., Nemcova, V. & Farska, I. Phospholipids and calcium alterations in platelets of schizophrenic patients. Physiol Res 46, 59-68 (1997).
56. Das, I. et al. Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. Biochem Biophys Res Commun 212, 375-380 (1995).
57. Baier, P. C. et al. A flow-cytometric method to investigate glutamate-receptorsensitivity in whole blood platelets-results from healthy controls and patients with schizophrenia. J Psychiatr Res 43, 585-591 (2009).
58. McOmish, C. E. et al. Phospholipase C-beta1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration. Mol Psychiatry 13, 661-672 (2008).
59. Lezcano, N. & Bergson, C. D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons. J Neurophysiol 87, 2167-2175 (2002).
60. Patel, J. C., Witkovsky, P., Avshalumov, M. V. & Rice, M. E. Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release. J Neurosci 29, 6568-6579 (2009).
61. Krupp, J. J., Vissel, B., Thomas, C. G., Heinemann, S. F. & Westbrook, G. L. Interactions of calmodulin and alpha-actinin with the NR1 subunit modulate Ca21-dependent inactivation of NMDA receptors. J Neurosci 19, 1165-1178 (1999).